Commit and Enlarged thyroid - a phase IV clinical study of FDA data
Summary:
We study 5,816 people who take Commit (nicotine polacrilex) or have Enlarged thyroid. No report of Enlarged thyroid is found in people who take Commit.
The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.
What is Commit?
Commit has active ingredients of nicotine polacrilex. eHealthMe is studying from 4,842 Commit users. Check the latest studies of Commit.
What is Enlarged Thyroid?
Enlarged thyroid is found to be associated with 279 drugs and 276 conditions by eHealthMe. Check the latest studies of Enlarged thyroid.
No report is found.
Do you take Commit and have Enlarged thyroid?
- Check whether Enlarged thyroid is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Commit:
- Commit (4,842 reports)
Enlarged thyroid treatments and more:
- Enlarged thyroid (974 reports)
How severe was Enlarged thyroid and when was it recovered:
Expand to all the drugs that have ingredients of nicotine polacrilex:
Browse all side effects of Commit:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Enlarged thyroid:
Browse all the conditions that are associated with Enlarged thyroid:
How the study uses the data?
The study uses data from the FDA. It is based on nicotine polacrilex (the active ingredients of Commit) and Commit (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Reflux Oesophagitis and drugs of ingredients of amoxicillin - now
- Could Fentanyl Transdermal System cause Dry Eyes Aggravated? - 2 seconds ago
- Idiopathic Thrombocytopenic Purpura (Itp) and drugs of ingredients of acetaminophen; hydrocodone bitartrate - 2 seconds ago
- Post-Traumatic Neck Syndrome and drugs of ingredients of celecoxib - 3 seconds ago
- Zyprexa and Hair Loss for Women aged 60+ - 6 seconds ago
- Zyprexa and Loss Of Hair for Women aged 60+ - 7 seconds ago
- Zyprexa and Hairloss for Women aged 60+ - 7 seconds ago
- Zyprexa and Baldness for Women aged 60+ - 7 seconds ago
- Zyprexa and Alopecia for Women aged 60+ - 7 seconds ago
- Zyprexa and Hair Thinning for Women aged 60+ - 8 seconds ago